Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects
- 14 May 2021
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (20)
Abstract
Significance: C28, a chemical compound identified by computational screening, selectively facilitates voltage-dependent activation of a cardiac potassium ion channel, I Ks . This compound reverses drug-induced prolongation of the electric signals across the cardiac cell membrane known as action potentials (APs) but minimally affects the normal AP at the same dosage. This outcome supports a computational prediction that enhancing voltage-dependent activation of I Ks could be a potential therapy for AP prolongation. This therapy would increase the safety and expand the therapeutic efficacy of many currently approved drugs that induce AP prolongation, which can trigger life-threatening cardiac arrhythmias.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Heart, Lung, and Blood Institute (HL126774)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK108989)
- HHS | NIH | National Institute of General Medical Sciences (GM109980)
- HHS | NIH | National Institute of General Medical Sciences (GM136409)
- American Heart Association (13GRNT16990076)
- China Scholarship Council (201206380052)
- HHS | NIH | U.S. National Library of Medicine (LM07089)
This publication has 53 references indexed in Scilit:
- Suppression of Phosphoinositide 3-Kinase Signaling and Alteration of Multiple Ion Currents in Drug-Induced Long QT SyndromeScience Translational Medicine, 2012
- KCNE1 enhances phosphatidylinositol 4,5-bisphosphate (PIP 2 ) sensitivity of I
Ks
to modulate channel activityProceedings of the National Academy of Sciences, 2011
- Overview of Basic Mechanisms of Cardiac ArrhythmiaCardiac Electrophysiology Clinics, 2011
- KCNE1 alters the voltage sensor movements necessary to open the KCNQ1 channel gateProceedings of the National Academy of Sciences, 2010
- KCNH2 pharmacogenomics summaryPharmacogenetics and Genomics, 2010
- KCNE1 Remodels the Voltage Sensor of Kv7.1 to Modulate Channel FunctionBiophysical Journal, 2010
- State-dependent electrostatic interactions of S4 arginines with E1 in S2 during Kv7.1 activationJournal of General Physiology, 2010
- Clinical use of and future perspectives on antiarrhythmic drugsEuropean Journal of Clinical Pharmacology, 2008
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- TASK-3, a New Member of the Tandem Pore K+ Channel FamilyJournal of Biological Chemistry, 2000